Literature DB >> 15293008

[Dual diagnosis of psychosis and addiction. From principles to practice].

E Gouzoulis-Mayfrank1.   

Abstract

The prevalence of comorbidity of psychosis and substance abuse/addiction has been on the rise during the last 10-20 years. Meanwhile, dual diagnosis patients (DD patients) represent a large core group among patients with schizophrenia, and they are difficult to treat. Biological, psychological, and social factors may account for the comorbidity, and the single factors may interact with each other. DD patients tend to have poor compliance and unfavorable outcomes with frequent psychotic relapses and hospitalizations. Efficient treatment models integrate traditional psychiatric therapy and therapy of addiction and modify or adjust the two components to each other. The most successful programs offer integrated treatment for both disorders in one setting. These programs focus on outpatient treatment, they offer pharmacotherapy, motivation therapy, psychoeducation, cognitive-behavioral therapy, and family interventions, and they can achieve significant improvements of social adjustment and decreases of substance use.

Entities:  

Mesh:

Year:  2004        PMID: 15293008     DOI: 10.1007/s00115-004-1692-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  56 in total

1.  Treating substance abuse in schizophrenia. An initial report.

Authors:  M E Bennett; A S Bellack; J S Gearon
Journal:  J Subst Abuse Treat       Date:  2001-03

Review 2.  Psychosocial approaches to dual diagnosis.

Authors:  R E Drake; K T Mueser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

3.  Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London.

Authors:  P J Duke; C Pantelis; M A McPhillips; T R Barnes
Journal:  Br J Psychiatry       Date:  2001-12       Impact factor: 9.319

4.  Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes.

Authors:  G De Leon; S Sacks; G Staines; K McKendrick
Journal:  Am J Drug Alcohol Abuse       Date:  2000-08       Impact factor: 3.829

5.  Substance abuse and the onset of schizophrenia.

Authors:  M Hambrecht; H Häfner
Journal:  Biol Psychiatry       Date:  1996-12-01       Impact factor: 13.382

6.  Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders.

Authors:  L Kofoed; J Kania; T Walsh; R M Atkinson
Journal:  Am J Psychiatry       Date:  1986-07       Impact factor: 18.112

Review 7.  Antidepressant for substance-abusing schizophrenic patients: a minireview.

Authors:  S G Siris; P C Bermanzohn; S E Mason; M A Shuwall
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1991       Impact factor: 5.067

Review 8.  Update on family psychoeducation for schizophrenia.

Authors:  L Dixon; C Adams; A Lucksted
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

9.  Schizophrenia, substance use, and brain morphology.

Authors:  G Scheller-Gilkey; R R Lewine; J Caudle; F W Brown
Journal:  Schizophr Res       Date:  1999-01-11       Impact factor: 4.939

10.  Dual Diagnosis Motivational Interviewing: a modification of Motivational Interviewing for substance-abusing patients with psychotic disorders.

Authors:  Steve Martino; Kathleen Carroll; Demetrios Kostas; Jennifer Perkins; Bruce Rounsaville
Journal:  J Subst Abuse Treat       Date:  2002-12
View more
  5 in total

Review 1.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

2.  Determinants of compulsory hospitalisation at admission and in the course of inpatient treatment in people with mental disorders-a retrospective analysis of health records of the four psychiatric hospitals of the city of Cologne.

Authors:  Sönke Johann Peters; Mario Schmitz-Buhl; Olaf Karasch; Jürgen Zielasek; Euphrosyne Gouzoulis-Mayfrank
Journal:  BMC Psychiatry       Date:  2022-07-14       Impact factor: 4.144

3.  [Use of an outpatient treatment center for cannabis abuse].

Authors:  F Hölscher; U Bonnet; N Scherbaum
Journal:  Nervenarzt       Date:  2008-05       Impact factor: 1.214

4.  A retrospective analysis of determinants of involuntary psychiatric in-patient treatment.

Authors:  Mario Schmitz-Buhl; Stefanie Kristiane Gairing; Christian Rietz; Peter Häussermann; Jürgen Zielasek; Euphrosyne Gouzoulis-Mayfrank
Journal:  BMC Psychiatry       Date:  2019-04-29       Impact factor: 3.630

5.  Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: the PERSEO (psychiatric emergency study and epidemiology) survey.

Authors:  Andrea Ballerini; Roberto M Boccalon; Giancarlo Boncompagni; Massimo Casacchia; Francesco Margari; Lina Minervini; Roberto Righi; Federico Russo; Andrea Salteri; Sonia Frediani; Andrea Rossi; Marco Scatigna
Journal:  Ann Gen Psychiatry       Date:  2007-11-05       Impact factor: 3.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.